Readmission following methotrexate treatment for tubal pregnancy
International Journal of Gynecology & Obstetrics · 2025-02 · 168 (2) · 852-853
DOI: 10.1002/ijgo.16106 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 14.12.2024. Verfasst von Bo Gao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Linqu People's Hospital, Weifang, Shandong, China. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Obstetrics, Linqu People's Hospital, Weifang, Shandong, China.
- Department of Obstetrics, Bin Zhou Central Hospital, BinZhou, Shandong, China.
- Department of Obstetrics, Qingyun County People's Hospital, DeZhou, Shandong, China.
- Department of Obstetrics and Gynecology, Binzhou Medical University Hospital, Binzhou, Shandong, China.
ORCID-Profile: Fei Su
Zitieren
APA
Gao, B., Gao, F. F., Xu, W., & Su, F. (2025). Readmission following methotrexate treatment for tubal pregnancy. International Journal of Gynecology & Obstetrics, 168(2), 852-853. https://doi.org/10.1002/ijgo.16106
Vancouver
Gao B, Gao FF, Xu W, Su F. Readmission following methotrexate treatment for tubal pregnancy. International Journal of Gynecology & Obstetrics. 2025;168(2):852-853. doi:10.1002/ijgo.16106
BibTeX
@article{Gao2025,
author = {Gao, Bo and Gao, Fang Fang and Xu, Wei and Su, Fei},
title = {Readmission following methotrexate treatment for tubal pregnancy},
journal = {International Journal of Gynecology & Obstetrics},
year = {2025},
volume = {168},
number = {2},
pages = {852--853},
doi = {10.1002/ijgo.16106}
}
EUVIMED